Home › NDC Lookup › RxCUI directory › RxCUI 1732186

100 ML epirubicin hydrochloride 2 MG/ML Injection — RxCUI 1732186

RxNorm drug concept · Semantic clinical drug
RxCUI 1732186 Semantic clinical drug · SCD ● Current RxNorm concept 2 FDA products 2 package NDCs Snapshot Jul 14, 2026

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1732186
Official name100 ML epirubicin hydrochloride 2 MG/ML Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asepirubicin HCl 200 MG per 100 ML Injection; epiRUBicin HCl 200 MG in 100 ML Injection
FDA products mapped2
Package NDCs mapped2
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Epirubicin: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Ellence (epirubicin) is a chemotherapy drug used after breast cancer surgery when cancer cells have been found in the lymph nodes under your arm. The goal is to reduce the risk of...
  • What exactly is Ellence used for, and why am I getting it with other chemo drugs?
  • Very common ones include nausea, vomiting, hair loss, mouth sores, and fatigue from low blood counts — your team will give you anti-nausea medication to help. Hair loss is usually...
  • What side effects should I expect, and which ones should make me call my doctor?
📖 Read our full Epirubicin guide →

🕸️ Concept Web — How 100 ML epirubicin hydrochloride 2 MG/ML Injectio... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 100 ML epirubicin hydrochloride 2 MG/ML Injection RxCUI 1732186

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Epirubicin 3995
    • Epirubicin hydrochloride 203213
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Ellence 203766
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Epirubicin Injection 1732171
    • Epirubicin hydrochloride Injection 2645322
    • Epirubicin Injectable Product 1163893
    • Epirubicin hydrochloride Injectable Product 2660556
    • Epirubicin Injection [Ellence] 1732174
    • Epirubicin hydrochloride Injection [Ellence] 2657033
    • Ellence Injectable Product 1174614
    • Injection 1649574
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Epirubicin hydrochloride 2 MG/ML SCDC · 836377
  • Epirubicin Injection SCDF · 1732171
  • Epirubicin hydrochloride Injection SCDFP · 2645322
  • Epirubicin Injectable Product SCDG · 1163893
  • Epirubicin hydrochloride Injectable Product SCDGP · 2660556

Brand-Name Concepts

  • 100 ML epirubicin hydrochloride 2 MG/ML Injection [Ellence] SBD · 1732187
  • Epirubicin hydrochloride 2 MG/ML [Ellence] SBDC · 836379
  • Epirubicin Injection [Ellence] SBDF · 1732174
  • Epirubicin hydrochloride Injection [Ellence] SBDFP · 2657033
  • Ellence Injectable Product SBDG · 1174614
  • Ellence BN · 203766

📦 FDA Products & Package NDCs

2 products · 2 package NDCs
2 package NDCs map to RxCUI 1732186 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00009-5091-25 1 VIAL, SINGLE-DOSE in 1 CARTON (0009-5091-25) / 25 mL in 1... Ellence Pharmacia & Upjohn Company LLC 2025-03-24
00009-5093-10 1 VIAL, SINGLE-DOSE in 1 CARTON (0009-5093-10) / 100 mL in... Ellence Pharmacia & Upjohn Company LLC 2025-03-24
Observed labelers: Pharmacia & Upjohn Company LLC (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
CodeDescriptorMapped packagesSources
J9178 Inj, epirubicin hcl, 2 mg 2 CMS
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.